Cargando…

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary

OBJECTIVE: In the 19 years since the Korean College of Neuropsychopharmacology and the Korean Society for Affective Disorders developed the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) in 2002, four revisions have been conducted. METHODS: To increase survey efficiency in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Jeong Seok, Bahk, Won-Myong, Woo, Young Sup, Park, Young-Min, Kim, Won, Jeong, Jong-Hyun, Shim, Se-Hoon, Lee, Jung Goo, Jang, Seung-Ho, Yang, Chan-Mo, Wang, Sheng-Min, Jung, Myung Hun, Sung, Hyung Mo, Choo, IL Han, Yoon, Bo-Hyun, Lee, Sang-Yeol, Jon, Duk-In, Min, Kyung Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553538/ https://www.ncbi.nlm.nih.gov/pubmed/34690130 http://dx.doi.org/10.9758/cpn.2021.19.4.751

Ejemplares similares

Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
por: Woo, Young Sup, et al.
Publicado: (2018)

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
por: Seo, Jeong Seok, et al.
Publicado: (2018)

The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo, Young Sup, et al.
Publicado: (2015)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2017)

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
por: Jang, Seung-Ho, et al.
Publicado: (2023)

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2023)

Prevalence and Comorbidities of Adult Attention-deficit/ hyperactivity Disorder in a Community Sample from Korea
por: Woo, Young Sup, et al.
Publicado: (2023)

Effect of Initial Ziprasidone Dose on Treatment Outcome of Korean Patients with Acute Manic or Mixed Episodes
por: Woo, Young Sup, et al.
Publicado: (2011)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
por: Bae, Seung Oh, et al.
Publicado: (2013)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder
por: Kang, Hangoeunbi, et al.
Publicado: (2023)

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
por: Woo, Young Sup, et al.
Publicado: (2017)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Erratum: Lee, J.G., et al. The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease. Brain Sciences 2019, 9(10), 285
por: Lee, Jung Goo, et al.
Publicado: (2019)

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
por: Lee, Jung Goo, et al.
Publicado: (2019)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2020)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
por: Song, Hoo Rim, et al.
Publicado: (2015)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study
por: Woo, Young Sup, et al.
Publicado: (2020)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
por: Choi, Won-Seok, et al.
Publicado: (2022)

The Brain–Gut–Microbiome Axis in Psychiatry
por: Jang, Seung-Ho, et al.
Publicado: (2020)

Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study
por: Chang, Seyeon, et al.
Publicado: (2021)

F3. A CASE OF LEUKOCYTOSIS ASSOCIATED WITH CLOZAPINE TREATMENT FOR THE MANAGEMENT OF CHRONIC SCHIZOPHRENIA
por: Song, Min-Kyu, et al.
Publicado: (2018)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder
por: Shim, Se-hoon, et al.
Publicado: (2021)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2014)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings
por: Jung, Young-Eun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_77equn36a59mlar57opv3e9jka